Hojin Choi Selected Research

Hojin Choi Research Topics

Disease

7	Dementia (Dementias) 01/2023 - 01/2018
6	Ischemic Stroke 04/2019 - 10/2012
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2012
4	Neoplasms (Cancer) 10/2019 - 09/2010
4	Cerebral Infarction 04/2019 - 10/2015
3	Cognitive Dysfunction 04/2024 - 01/2017
3	Hypertension (High Blood Pressure) 02/2023 - 10/2015
2	Stroke (Strokes) 02/2023 - 09/2021
2	Gout 02/2023 - 01/2023
2	Brain Ischemia (Cerebral Ischemia) 09/2021 - 10/2019
2	Hypoxia (Hypoxemia) 01/2019 - 10/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2018 - 01/2012
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2016 - 10/2012
2	Inflammation (Inflammations) 06/2012 - 05/2012
2	Erectile Dysfunction 01/2010 - 12/2008
1	Atrophy 04/2024
1	Diabetes Complications 02/2023
1	Motor Neuron Disease (Primary Lateral Sclerosis) 02/2023
1	Dyslipidemias (Dyslipidemia) 02/2023
1	Ovarian Teratoma 09/2022
1	COVID-19 09/2022
1	Encephalitis (Encephalitis, Rasmussen) 09/2022
1	Reperfusion Injury 09/2021
1	Glioblastoma (Glioblastoma Multiforme) 10/2020
1	Tolosa-Hunt Syndrome 04/2020
1	painful Ophthalmoplegia 04/2020
1	Brain Neoplasms (Brain Tumor) 10/2019
1	Meningioma (Meningiomas) 10/2019
1	Neuroblastoma 10/2019
1	Pituitary Neoplasms (Pituitary Adenoma) 10/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Dyskinesias (Dyskinesia) 01/2018
1	Amyloid Plaque 12/2017
1	Infarction (Infarctions) 10/2015
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2015
1	Lacunar Stroke 03/2015
1	Brain Infarction 03/2015

Drug/Important Bio-Agent (IBA)

5	Neuroprotective AgentsIBA 09/2021 - 10/2015
5	Proteins (Proteins, Gene)FDA Link 10/2020 - 10/2012
3	Oxygen (Dioxygen)IBA 09/2021 - 12/2016
3	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 12/2016
2	Biomarkers (Surrogate Marker)IBA 04/2024 - 03/2015
2	Intracellular Signaling Peptides and ProteinsIBA 10/2019 - 10/2012
2	Glycogen Synthase Kinase 3IBA 01/2018 - 10/2012
2	CarrageenanIBA 06/2012 - 05/2012
2	Acetic Acid (Vinegar)FDA LinkGeneric 06/2012 - 05/2012
2	NitritesIBA 06/2012 - 05/2012
2	ProdrugsIBA 11/2010 - 09/2010
2	Valine (L-Valine)FDA Link 11/2010 - 09/2010
2	Tubulin ModulatorsIBA 11/2010 - 09/2010
1	Uric Acid (Urate)IBA 02/2023
1	SteroidsIBA 01/2023
1	Febuxostat FDA Link 01/2023
1	Allopurinol (Remid)FDA LinkGeneric 01/2023
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Donepezil (Aricept)FDA LinkGeneric 01/2022
1	Amyloid (Amyloid Fibrils)IBA 09/2021
1	Methotrexate (Mexate)FDA LinkGeneric 04/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2020
1	Small Interfering RNA (siRNA)IBA 10/2019
1	Leucine (L-Leucine)FDA Link 10/2019
1	Amlodipine (Norvasc)FDA LinkGeneric 10/2019
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 10/2019
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 10/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2019
1	polyacrylamideIBA 10/2019
1	Atorvastatin (Lipitor)FDA Link 04/2019
1	ZincIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Acetylcarnitine (Alcar)IBA 03/2018
1	SynucleinsIBA 01/2018
1	CateninsIBA 01/2018
1	quinone (benzoquinone)IBA 01/2018
1	Levodopa (L Dopa)FDA LinkGeneric 01/2018
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018
1	Glycogen Synthase (Synthase I)IBA 01/2018
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018
1	Clopidogrel (Plavix)FDA Link 01/2018
1	Amyloid beta-PeptidesIBA 12/2017
1	candesartanIBA 09/2017
1	Angiotensin Receptor AntagonistsIBA 09/2017
1	Glycogen Synthase KinasesIBA 12/2016
1	cilnidipineIBA 10/2015
1	Antihypertensive Agents (Antihypertensives)IBA 10/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2015
1	Therapeutic UsesIBA 10/2015
1	Macrophage Migration-Inhibitory FactorsIBA 03/2015
1	HMGB1 Protein (HMG1)IBA 03/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015

Therapy/Procedure

5	Activities of Daily Living (ADL) 04/2024 - 01/2017
4	Therapeutics 12/2016 - 12/2008
1	Salpingo-oophorectomy 09/2022
1	Patient Care 01/2022
1	Chemoradiotherapy 10/2020
1	Cognitive Training 08/2020
1	Medical Day Care (Partial Hospitalization) 08/2020